Related Experiment Videos
A prospective study on corpus luteum function and breast cancer risk
I den Tonkelaar1, M A Blankenstein, H J Collette
1Department of Epidemiology, University of Utrecht, The Netherlands.
Summary
This study found no link between anovulation and breast cancer risk. Researchers compared pregnanediol levels in women with breast cancer and controls, finding no significant differences.
Area of Science:
- Reproductive Endocrinology
- Oncology
- Epidemiology
Background:
- Anovulation and luteal phase defects are potential risk factors for breast cancer.
- Previous research suggests hormonal imbalances may influence breast cancer development.
Purpose of the Study:
- To investigate the association between anovulation or luteal insufficiency and breast cancer risk.
- To determine if pregnanediol levels differ between breast cancer patients and controls.
Main Methods:
- A case-control study nested within a cohort of 12,000 women aged 40-49.
- Urine samples collected on day 22 of menstrual cycles were assayed for pregnanediol and creatinine.
- Comparison of pregnanediol/creatinine ratios between 53 breast cancer cases and matched controls.
Main Results:
- No significant difference was observed in the pregnanediol/creatinine ratio between breast cancer cases and controls.
- The study did not find evidence to support the hypothesis linking luteal insufficiency to increased breast cancer risk.
Conclusions:
- The findings do not support the hypothesis that women with luteal insufficiency are at increased risk for breast cancer.
- Further investigation is needed regarding the potential association between later menopause and breast cancer, which may complicate interpretation.